statistiche ricercatore

Continente	#
NA - Nord America	963
AS - Asia	349
EU - Europa	257
SA - Sud America	63
Continente sconosciuto - Info sul continente non disponibili	20
AF - Africa	7
Totale	1.659

Nazione	#
US - Stati Uniti d'America	943
SG - Singapore	162
DE - Germania	80
CN - Cina	74
UA - Ucraina	62
BR - Brasile	49
HK - Hong Kong	29
VN - Vietnam	22
IT - Italia	20
FI - Finlandia	19
IN - India	18
FR - Francia	17
RU - Federazione Russa	15
TR - Turchia	14
CA - Canada	11
IE - Irlanda	10
GB - Regno Unito	9
AR - Argentina	6
ID - Indonesia	6
SE - Svezia	6
BD - Bangladesh	5
CZ - Repubblica Ceca	5
IR - Iran	5
MX - Messico	5
IQ - Iraq	3
NL - Olanda	3
AT - Austria	2
CL - Cile	2
EC - Ecuador	2
EG - Egitto	2
ES - Italia	2
JP - Giappone	2
PL - Polonia	2
PY - Paraguay	2
ZA - Sudafrica	2
AZ - Azerbaigian	1
BB - Barbados	1
BG - Bulgaria	1
BH - Bahrain	1
BO - Bolivia	1
BZ - Belize	1
CO - Colombia	1
CR - Costa Rica	1
DZ - Algeria	1
EE - Estonia	1
JM - Giamaica	1
KE - Kenya	1
KG - Kirghizistan	1
KR - Corea	1
LA - Repubblica Popolare Democratica del Laos	1
LT - Lituania	1
MA - Marocco	1
NO - Norvegia	1
PH - Filippine	1
PK - Pakistan	1
PT - Portogallo	1
SA - Arabia Saudita	1
UZ - Uzbekistan	1
Totale	1.639

Nome	#
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome.	196
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus	184
Infliximab in Crohn's disease: a look at the (not so distant) future.	179
Selective effect of infliximab on the inflammatory component of a colonic stricture in Crohn's disease	178
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS	171
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts.	170
Low-dose maintenance therapy with infliximab prevents postsurgical recurrence of Crohn's disease.	162
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION	161
Differential Proteomic Analysis of Subfractioned Human Hepatocellular Carcinoma Tissues	154
Lack of prognostic predictive value of hepatic agobiopsy in a group of patients operated of hepatic resection for hepatocellular carcinoma	104
Totale	1.659

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	94	0	0	0	3	0	6	4	3	1	15	52	10
2022/2023	132	11	13	5	14	14	27	0	11	25	1	3	8
2023/2024	23	6	4	0	0	2	0	0	1	6	3	0	1
2024/2025	224	10	16	7	14	20	8	9	12	51	14	30	33
2025/2026	425	53	57	30	41	63	35	52	15	22	29	22	6
2026/2027	65	10	48	7	0	0	0	0	0	0	0	0	0
Totale													1.659